supplementary figure 1.pdf (1022.45 kB)
Supplementary figure 1.pdf: A Phase I trial of talazoparib in patients with advanced hematologic malignancies
figure
posted on 2021-10-23, 12:03 authored by Ajay K Gopal, Rakesh Popat, Ryan J Mattison, Tobias Menne, Adrian Bloor, Terry Gaymes, Asim Khwaja, Mark Juckett, Ying Chen, Matthew J Cotter, Ghulam J MuftiSupplementary Figure 1. Dose linearity and
proportionality in plasma following multiple doses of talazoparib.